Revision history of "Adoptive Cancer Immunotherapy with tumor infiltrating T-lymphocytes (ACT-TIL): selection and rejuvenation of tumor-specific T cells to increase their therapeutic efficacy." (Q3155054)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 October 2024

  • curprev 22:4922:49, 9 October 2024DG Regio talk contribs 86,019 bytes −17 Changed label, description and/or aliases in pt
  • curprev 22:4922:49, 9 October 2024DG Regio talk contribs 86,036 bytes +55 Set a claim value: summary (P836): O sucesso dos ACT-TILs no tratamento do melanoma avançado incentiva a extensão desta terapia a outras doenças neoplásicas que são difíceis de curar. Mas, ao contrário do melanoma, os TILs extraídos de outros tumores são mal expandidos e têm pouca reatividade antitumoral. O nosso objetivo é melhorar a eficácia antitumoral do ACT-TIL através de: (1) a selecção do repertório tumor-específico de TILs com maior eficácia terapêutica; e (2) o rejuvenescime...

23 March 2024

20 December 2023

12 June 2023

10 June 2023

4 August 2022

  • curprev 08:3508:35, 4 August 2022DG Regio talk contribs 84,708 bytes +58,943 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

12 October 2021

  • curprev 15:4415:44, 12 October 2021DG Regio talk contribs 13,325 bytes +2,647 Created claim: summary (P836): The success of ACT-TILs in the treatment of advanced melanoma encourages the extension of this therapy to other neoplastic diseases that are difficult to cure. But, unlike melanoma, TILs extracted from other tumors are poorly expanded and have little antitumor reactivity. Our goal is to improve the antitumor efficacy of ACT-TIL by: (1) the selection of tumor-specific TILs repertoire with greater therapeutic efficacy; and (2) the rejuvenation of...
  • curprev 15:4415:44, 12 October 2021DG Regio talk contribs 10,678 bytes −2,647 Removed claim: summary (P836): The success of ACT-TILs in the treatment of advanced melanoma encourages the extension of this therapy to other neoplastic diseases that are difficult to cure. But, unlike melanoma, TILs extracted from other tumors are poorly expanded and have little antitumor reactivity. Our goal is to improve the antitumor efficacy of ACT-TIL by: (1) the selection of tumor-specific TILs repertoire with greater therapeutic efficacy; and (2) the rejuvenation o...
  • curprev 15:0715:07, 12 October 2021DG Regio talk contribs 13,325 bytes +231 Changed label, description and/or aliases in en: translated_label
  • curprev 15:0715:07, 12 October 2021DG Regio talk contribs 13,094 bytes +2,647 Created claim: summary (P836): The success of ACT-TILs in the treatment of advanced melanoma encourages the extension of this therapy to other neoplastic diseases that are difficult to cure. But, unlike melanoma, TILs extracted from other tumors are poorly expanded and have little antitumor reactivity. Our goal is to improve the antitumor efficacy of ACT-TIL by: (1) the selection of tumor-specific TILs repertoire with greater therapeutic efficacy; and (2) the rejuvenation of...

10 October 2021

9 October 2021

8 October 2021